Health Secretary Robert F. Kennedy Jr. has initiated an FDA review of mifepristone, the drug used in approximately two-thirds of all abortions in the United States.
This move has raised concerns among abortion rights advocates, who worry that the FDA might impose restrictions on the pill’s availability—even in states where abortion remains legal.
Dr. Celine Gounder provides further insight into the implications of this review and what it could mean for access to abortion medication across the country.
https://www.cbsnews.com/video/what-to-know-about-fda-review-of-mifepristone/
